Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
151 |
1672 |
4.55e-22 |
2.117e-18 |
2 |
NEUROGENESIS |
134 |
1402 |
1.049e-21 |
2.442e-18 |
3 |
REGULATION OF CELL DIFFERENTIATION |
136 |
1492 |
3.535e-20 |
5.482e-17 |
4 |
REGULATION OF CELL DEVELOPMENT |
93 |
836 |
2.088e-19 |
2.429e-16 |
5 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
86 |
750 |
8.038e-19 |
7.48e-16 |
6 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
138 |
1656 |
4.352e-17 |
3.029e-14 |
7 |
POSITIVE REGULATION OF GENE EXPRESSION |
142 |
1733 |
5.859e-17 |
3.029e-14 |
8 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
85 |
788 |
5.636e-17 |
3.029e-14 |
9 |
CIRCULATORY SYSTEM DEVELOPMENT |
85 |
788 |
5.636e-17 |
3.029e-14 |
10 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
145 |
1791 |
7.201e-17 |
3.351e-14 |
11 |
REGULATION OF HYDROLASE ACTIVITY |
118 |
1327 |
1.091e-16 |
4.617e-14 |
12 |
TISSUE DEVELOPMENT |
128 |
1518 |
3.009e-16 |
1.167e-13 |
13 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
105 |
1142 |
7.222e-16 |
2.585e-13 |
14 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
141 |
1784 |
1.565e-15 |
5.202e-13 |
15 |
REGULATION OF GTPASE ACTIVITY |
74 |
673 |
2.49e-15 |
7.723e-13 |
16 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
80 |
771 |
4.461e-15 |
1.297e-12 |
17 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
124 |
1518 |
1.024e-14 |
2.803e-12 |
18 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
110 |
1275 |
1.117e-14 |
2.888e-12 |
19 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
94 |
1008 |
1.209e-14 |
2.96e-12 |
20 |
CELL DEVELOPMENT |
118 |
1426 |
2.05e-14 |
4.77e-12 |
21 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
93 |
1021 |
6.953e-14 |
1.541e-11 |
22 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
132 |
1710 |
9.05e-14 |
1.914e-11 |
23 |
LOCOMOTION |
98 |
1114 |
1.174e-13 |
2.376e-11 |
24 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
71 |
689 |
2.424e-13 |
4.699e-11 |
25 |
RESPONSE TO ENDOGENOUS STIMULUS |
116 |
1450 |
3.56e-13 |
6.625e-11 |
26 |
CELL PROJECTION ORGANIZATION |
84 |
902 |
3.859e-13 |
6.906e-11 |
27 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
101 |
1192 |
4.833e-13 |
8.328e-11 |
28 |
NEURON DIFFERENTIATION |
82 |
874 |
5.082e-13 |
8.445e-11 |
29 |
POSITIVE REGULATION OF CELL COMMUNICATION |
120 |
1532 |
5.567e-13 |
8.931e-11 |
30 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
134 |
1805 |
1.028e-12 |
1.594e-10 |
31 |
ORGAN MORPHOGENESIS |
79 |
841 |
1.32e-12 |
1.982e-10 |
32 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
111 |
1395 |
1.762e-12 |
2.562e-10 |
33 |
EPITHELIUM DEVELOPMENT |
85 |
945 |
1.819e-12 |
2.564e-10 |
34 |
HEART DEVELOPMENT |
54 |
466 |
2.228e-12 |
3.048e-10 |
35 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
88 |
1004 |
2.944e-12 |
3.914e-10 |
36 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
122 |
1618 |
4.634e-12 |
5.99e-10 |
37 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
73 |
767 |
5.377e-12 |
6.762e-10 |
38 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
138 |
1929 |
6.693e-12 |
8.195e-10 |
39 |
REGULATION OF NEURON DIFFERENTIATION |
59 |
554 |
7.329e-12 |
8.744e-10 |
40 |
HEAD DEVELOPMENT |
69 |
709 |
7.755e-12 |
9.02e-10 |
41 |
VASCULATURE DEVELOPMENT |
53 |
469 |
9.463e-12 |
1.048e-09 |
42 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
55 |
498 |
9.403e-12 |
1.048e-09 |
43 |
NEURON PROJECTION DEVELOPMENT |
58 |
545 |
1.145e-11 |
1.239e-09 |
44 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
95 |
1152 |
1.208e-11 |
1.277e-09 |
45 |
INTRACELLULAR SIGNAL TRANSDUCTION |
118 |
1572 |
1.48e-11 |
1.53e-09 |
46 |
CELLULAR COMPONENT MORPHOGENESIS |
80 |
900 |
1.567e-11 |
1.569e-09 |
47 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
74 |
801 |
1.585e-11 |
1.569e-09 |
48 |
TUBE DEVELOPMENT |
58 |
552 |
1.918e-11 |
1.859e-09 |
49 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
75 |
823 |
2.199e-11 |
2.088e-09 |
50 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
55 |
513 |
2.992e-11 |
2.784e-09 |
51 |
MORPHOGENESIS OF AN EPITHELIUM |
47 |
400 |
3.819e-11 |
3.485e-09 |
52 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
82 |
957 |
5.436e-11 |
4.864e-09 |
53 |
REGULATION OF CELL PROLIFERATION |
112 |
1496 |
6.246e-11 |
5.484e-09 |
54 |
BLOOD VESSEL MORPHOGENESIS |
44 |
364 |
6.425e-11 |
5.536e-09 |
55 |
EMBRYO DEVELOPMENT |
78 |
894 |
7.056e-11 |
5.969e-09 |
56 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
49 |
437 |
7.737e-11 |
6.429e-09 |
57 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
104 |
1360 |
1.002e-10 |
8.177e-09 |
58 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
111 |
1492 |
1.124e-10 |
9.019e-09 |
59 |
REGULATION OF MAPK CASCADE |
63 |
660 |
1.477e-10 |
1.165e-08 |
60 |
PROTEIN PHOSPHORYLATION |
80 |
944 |
1.62e-10 |
1.256e-08 |
61 |
EMBRYONIC MORPHOGENESIS |
55 |
539 |
1.966e-10 |
1.5e-08 |
62 |
REGULATION OF CELL PROJECTION ORGANIZATION |
56 |
558 |
2.514e-10 |
1.887e-08 |
63 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
77 |
905 |
3.057e-10 |
2.258e-08 |
64 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
75 |
872 |
3.241e-10 |
2.356e-08 |
65 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
50 |
472 |
3.7e-10 |
2.649e-08 |
66 |
TISSUE MORPHOGENESIS |
54 |
533 |
3.758e-10 |
2.649e-08 |
67 |
RESPONSE TO GROWTH FACTOR |
50 |
475 |
4.613e-10 |
3.203e-08 |
68 |
NEURON DEVELOPMENT |
63 |
687 |
7.517e-10 |
5.144e-08 |
69 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
58 |
609 |
8.911e-10 |
6.009e-08 |
70 |
REGULATION OF CELL DEATH |
107 |
1472 |
9.568e-10 |
6.36e-08 |
71 |
REGULATION OF KINASE ACTIVITY |
68 |
776 |
1.058e-09 |
6.933e-08 |
72 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
80 |
983 |
1.093e-09 |
7.065e-08 |
73 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
88 |
1135 |
1.668e-09 |
1.063e-07 |
74 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
82 |
1036 |
2.45e-09 |
1.514e-07 |
75 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
82 |
1036 |
2.45e-09 |
1.514e-07 |
76 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
44 |
408 |
2.474e-09 |
1.514e-07 |
77 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
59 |
643 |
2.605e-09 |
1.574e-07 |
78 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
26 |
167 |
2.811e-09 |
1.658e-07 |
79 |
TUBE MORPHOGENESIS |
38 |
323 |
2.816e-09 |
1.658e-07 |
80 |
REGULATION OF CELL ADHESION |
58 |
629 |
2.98e-09 |
1.733e-07 |
81 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
35 |
285 |
3.878e-09 |
2.228e-07 |
82 |
REGULATION OF TRANSFERASE ACTIVITY |
76 |
946 |
5.185e-09 |
2.942e-07 |
83 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
63 |
724 |
5.877e-09 |
3.294e-07 |
84 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
74 |
917 |
6.927e-09 |
3.837e-07 |
85 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
67 |
799 |
8.363e-09 |
4.578e-07 |
86 |
GROWTH |
43 |
410 |
8.692e-09 |
4.703e-07 |
87 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
39 |
352 |
9.534e-09 |
5.099e-07 |
88 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
123 |
1848 |
9.697e-09 |
5.127e-07 |
89 |
NEGATIVE REGULATION OF CELL DEATH |
71 |
872 |
9.919e-09 |
5.186e-07 |
90 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
71 |
876 |
1.196e-08 |
6.184e-07 |
91 |
NEURON PROJECTION MORPHOGENESIS |
42 |
402 |
1.449e-08 |
7.409e-07 |
92 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
30 |
232 |
1.534e-08 |
7.758e-07 |
93 |
CELL MOTILITY |
68 |
835 |
2.057e-08 |
1.008e-06 |
94 |
LOCALIZATION OF CELL |
68 |
835 |
2.057e-08 |
1.008e-06 |
95 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
43 |
422 |
2.036e-08 |
1.008e-06 |
96 |
DEVELOPMENTAL GROWTH |
37 |
333 |
2.121e-08 |
1.028e-06 |
97 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
55 |
616 |
2.358e-08 |
1.131e-06 |
98 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
33 |
279 |
2.73e-08 |
1.296e-06 |
99 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
50 |
541 |
3.511e-08 |
1.634e-06 |
100 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
50 |
541 |
3.511e-08 |
1.634e-06 |
101 |
POSITIVE REGULATION OF CELL PROLIFERATION |
66 |
814 |
3.965e-08 |
1.827e-06 |
102 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
35 |
312 |
4.013e-08 |
1.831e-06 |
103 |
REGULATION OF OSSIFICATION |
25 |
178 |
4.706e-08 |
2.126e-06 |
104 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
41 |
404 |
4.871e-08 |
2.179e-06 |
105 |
REGULATION OF EPITHELIAL CELL MIGRATION |
24 |
166 |
4.959e-08 |
2.198e-06 |
106 |
FACE DEVELOPMENT |
13 |
50 |
5.485e-08 |
2.408e-06 |
107 |
REGULATION OF CELL JUNCTION ASSEMBLY |
15 |
68 |
5.779e-08 |
2.513e-06 |
108 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
54 |
616 |
5.846e-08 |
2.519e-06 |
109 |
REGULATION OF CYTOSKELETON ORGANIZATION |
47 |
502 |
6.165e-08 |
2.632e-06 |
110 |
PHOSPHORYLATION |
88 |
1228 |
6.698e-08 |
2.833e-06 |
111 |
STEM CELL PROLIFERATION |
14 |
60 |
7.509e-08 |
3.148e-06 |
112 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
38 |
368 |
9.62e-08 |
3.997e-06 |
113 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
21 |
138 |
1.391e-07 |
5.729e-06 |
114 |
CELL PART MORPHOGENESIS |
54 |
633 |
1.423e-07 |
5.809e-06 |
115 |
UROGENITAL SYSTEM DEVELOPMENT |
33 |
299 |
1.437e-07 |
5.816e-06 |
116 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
28 |
229 |
1.529e-07 |
6.133e-06 |
117 |
POSITIVE REGULATION OF MAPK CASCADE |
44 |
470 |
1.638e-07 |
6.458e-06 |
118 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
44 |
470 |
1.638e-07 |
6.458e-06 |
119 |
SKELETAL SYSTEM DEVELOPMENT |
43 |
455 |
1.743e-07 |
6.817e-06 |
120 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
79 |
1087 |
1.882e-07 |
7.298e-06 |
121 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
46 |
505 |
1.906e-07 |
7.328e-06 |
122 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
33 |
303 |
1.963e-07 |
7.426e-06 |
123 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
33 |
303 |
1.963e-07 |
7.426e-06 |
124 |
NEURON PROJECTION GUIDANCE |
26 |
205 |
2.047e-07 |
7.681e-06 |
125 |
REGULATION OF MAP KINASE ACTIVITY |
34 |
319 |
2.153e-07 |
8.015e-06 |
126 |
AMEBOIDAL TYPE CELL MIGRATION |
22 |
154 |
2.206e-07 |
8.146e-06 |
127 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
30 |
262 |
2.381e-07 |
8.724e-06 |
128 |
SENSORY ORGAN DEVELOPMENT |
45 |
493 |
2.443e-07 |
8.882e-06 |
129 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
33 |
306 |
2.47e-07 |
8.908e-06 |
130 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
94 |
1381 |
2.508e-07 |
8.977e-06 |
131 |
EPITHELIAL CELL DIFFERENTIATION |
45 |
495 |
2.74e-07 |
9.733e-06 |
132 |
ANGIOGENESIS |
32 |
293 |
2.817e-07 |
9.928e-06 |
133 |
SINGLE ORGANISM BEHAVIOR |
38 |
384 |
2.872e-07 |
9.984e-06 |
134 |
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
9 |
25 |
2.875e-07 |
9.984e-06 |
135 |
TAXIS |
43 |
464 |
2.994e-07 |
1.032e-05 |
136 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
43 |
465 |
3.176e-07 |
1.086e-05 |
137 |
POSITIVE REGULATION OF KINASE ACTIVITY |
44 |
482 |
3.317e-07 |
1.119e-05 |
138 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
19 |
121 |
3.3e-07 |
1.119e-05 |
139 |
NEGATIVE REGULATION OF GENE EXPRESSION |
99 |
1493 |
3.943e-07 |
1.32e-05 |
140 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
41 |
437 |
4.087e-07 |
1.358e-05 |
141 |
EPITHELIAL CELL DEVELOPMENT |
24 |
186 |
4.345e-07 |
1.434e-05 |
142 |
CELL FATE COMMITMENT |
27 |
227 |
4.44e-07 |
1.455e-05 |
143 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
12 |
50 |
4.622e-07 |
1.504e-05 |
144 |
REGULATION OF CELL MATRIX ADHESION |
16 |
90 |
4.979e-07 |
1.609e-05 |
145 |
REGULATION OF SYNAPSE ORGANIZATION |
18 |
113 |
5.39e-07 |
1.73e-05 |
146 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
18 |
114 |
6.165e-07 |
1.951e-05 |
147 |
AXIS ELONGATION |
9 |
27 |
6.137e-07 |
1.951e-05 |
148 |
REGULATION OF VASCULATURE DEVELOPMENT |
27 |
233 |
7.47e-07 |
2.348e-05 |
149 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
34 |
337 |
7.767e-07 |
2.426e-05 |
150 |
BIOLOGICAL ADHESION |
74 |
1032 |
7.854e-07 |
2.436e-05 |
151 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
30 |
278 |
8.515e-07 |
2.624e-05 |
152 |
REGULATION OF CELL MORPHOGENESIS |
47 |
552 |
9.806e-07 |
2.982e-05 |
153 |
HEAD MORPHOGENESIS |
10 |
36 |
9.784e-07 |
2.982e-05 |
154 |
FOREBRAIN DEVELOPMENT |
35 |
357 |
1.048e-06 |
3.167e-05 |
155 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
47 |
554 |
1.085e-06 |
3.258e-05 |
156 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
38 |
406 |
1.149e-06 |
3.424e-05 |
157 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
19 |
131 |
1.155e-06 |
3.424e-05 |
158 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
15 |
85 |
1.244e-06 |
3.664e-05 |
159 |
CELLULAR RESPONSE TO LIPID |
41 |
457 |
1.305e-06 |
3.819e-05 |
160 |
SYNAPSE ORGANIZATION |
20 |
145 |
1.369e-06 |
3.98e-05 |
161 |
REGULATION OF ORGAN MORPHOGENESIS |
27 |
242 |
1.57e-06 |
4.538e-05 |
162 |
REGULATION OF CELL SUBSTRATE ADHESION |
22 |
173 |
1.669e-06 |
4.794e-05 |
163 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
57 |
740 |
1.778e-06 |
5.075e-05 |
164 |
REGULATION OF DEVELOPMENTAL GROWTH |
30 |
289 |
1.916e-06 |
5.435e-05 |
165 |
WNT SIGNALING PATHWAY |
34 |
351 |
1.955e-06 |
5.513e-05 |
166 |
MUSCLE TISSUE DEVELOPMENT |
29 |
275 |
2.064e-06 |
5.786e-05 |
167 |
BEHAVIOR |
44 |
516 |
2.094e-06 |
5.833e-05 |
168 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
75 |
1079 |
2.109e-06 |
5.842e-05 |
169 |
INOSITOL LIPID MEDIATED SIGNALING |
18 |
124 |
2.171e-06 |
5.978e-05 |
170 |
ACTIN FILAMENT BASED PROCESS |
40 |
450 |
2.209e-06 |
6.047e-05 |
171 |
POST EMBRYONIC DEVELOPMENT |
15 |
89 |
2.275e-06 |
6.191e-05 |
172 |
POSITIVE REGULATION OF LOCOMOTION |
38 |
420 |
2.601e-06 |
6.995e-05 |
173 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
97 |
1517 |
2.592e-06 |
6.995e-05 |
174 |
REGULATION OF SYNAPSE ASSEMBLY |
14 |
79 |
2.662e-06 |
7.118e-05 |
175 |
PROTEIN LOCALIZATION |
111 |
1805 |
2.874e-06 |
7.641e-05 |
176 |
REGULATION OF SYSTEM PROCESS |
43 |
507 |
3.138e-06 |
8.296e-05 |
177 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
16 |
103 |
3.208e-06 |
8.433e-05 |
178 |
REGULATION OF FIBROBLAST PROLIFERATION |
14 |
81 |
3.622e-06 |
9.469e-05 |
179 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
16 |
104 |
3.652e-06 |
9.494e-05 |
180 |
RESPONSE TO LIPID |
64 |
888 |
3.83e-06 |
9.901e-05 |
181 |
RAS PROTEIN SIGNAL TRANSDUCTION |
19 |
143 |
4.394e-06 |
0.000113 |
182 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
53 |
691 |
4.66e-06 |
0.0001191 |
183 |
CYTOSKELETON ORGANIZATION |
61 |
838 |
4.765e-06 |
0.0001212 |
184 |
ENDOTHELIAL CELL DIFFERENTIATION |
13 |
72 |
4.863e-06 |
0.000123 |
185 |
MUSCLE STRUCTURE DEVELOPMENT |
38 |
432 |
5.05e-06 |
0.000127 |
186 |
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT |
8 |
26 |
5.205e-06 |
0.0001302 |
187 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
9 |
34 |
5.339e-06 |
0.0001328 |
188 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
118 |
1977 |
5.624e-06 |
0.0001392 |
189 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
25 |
232 |
7.046e-06 |
0.0001735 |
190 |
BODY MORPHOGENESIS |
10 |
44 |
7.146e-06 |
0.000175 |
191 |
CELLULAR MACROMOLECULE LOCALIZATION |
81 |
1234 |
7.205e-06 |
0.0001755 |
192 |
REGULATION OF TRANSPORT |
109 |
1804 |
7.896e-06 |
0.0001914 |
193 |
EYE DEVELOPMENT |
31 |
326 |
7.998e-06 |
0.0001928 |
194 |
REGULATION OF CELL CYCLE |
66 |
949 |
8.711e-06 |
0.0002089 |
195 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
16 |
112 |
9.724e-06 |
0.000232 |
196 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
23 |
207 |
9.822e-06 |
0.0002332 |
197 |
REGULATION OF BINDING |
28 |
283 |
1.042e-05 |
0.0002462 |
198 |
REGULATION OF STEM CELL DIFFERENTIATION |
16 |
113 |
1.091e-05 |
0.0002565 |
199 |
REGULATION OF HOMEOSTATIC PROCESS |
38 |
447 |
1.107e-05 |
0.0002588 |
200 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
17 |
126 |
1.127e-05 |
0.0002623 |
201 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
12 |
67 |
1.223e-05 |
0.0002804 |
202 |
REGULATION OF EMBRYONIC DEVELOPMENT |
16 |
114 |
1.223e-05 |
0.0002804 |
203 |
MODULATION OF SYNAPTIC TRANSMISSION |
29 |
301 |
1.213e-05 |
0.0002804 |
204 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
18 |
140 |
1.238e-05 |
0.0002824 |
205 |
ENDOTHELIUM DEVELOPMENT |
14 |
90 |
1.287e-05 |
0.0002894 |
206 |
NEUROBLAST PROLIFERATION |
8 |
29 |
1.285e-05 |
0.0002894 |
207 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
15 |
102 |
1.284e-05 |
0.0002894 |
208 |
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
10 |
47 |
1.338e-05 |
0.0002992 |
209 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
16 |
115 |
1.369e-05 |
0.0003048 |
210 |
ORGAN GROWTH |
12 |
68 |
1.432e-05 |
0.0003173 |
211 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
16 |
116 |
1.53e-05 |
0.0003375 |
212 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
21 |
184 |
1.572e-05 |
0.000345 |
213 |
TELENCEPHALON DEVELOPMENT |
24 |
228 |
1.585e-05 |
0.0003463 |
214 |
RESPONSE TO HORMONE |
62 |
893 |
1.729e-05 |
0.000376 |
215 |
REGULATION OF GROWTH |
48 |
633 |
1.765e-05 |
0.0003819 |
216 |
EMBRYONIC ORGAN DEVELOPMENT |
35 |
406 |
1.82e-05 |
0.000392 |
217 |
ODONTOGENESIS |
15 |
105 |
1.833e-05 |
0.000393 |
218 |
RESPONSE TO WOUNDING |
44 |
563 |
1.906e-05 |
0.0004049 |
219 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
16 |
118 |
1.904e-05 |
0.0004049 |
220 |
NEGATIVE REGULATION OF MAPK CASCADE |
18 |
145 |
2.013e-05 |
0.0004258 |
221 |
REGULATION OF FAT CELL DIFFERENTIATION |
15 |
106 |
2.057e-05 |
0.0004331 |
222 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
17 |
133 |
2.317e-05 |
0.0004856 |
223 |
RESPONSE TO STEROID HORMONE |
40 |
497 |
2.339e-05 |
0.0004881 |
224 |
MESENCHYME DEVELOPMENT |
21 |
190 |
2.56e-05 |
0.0005317 |
225 |
POSITIVE REGULATION OF SYNAPSE ASSEMBLY |
11 |
61 |
2.628e-05 |
0.0005435 |
226 |
RHYTHMIC PROCESS |
28 |
298 |
2.697e-05 |
0.0005552 |
227 |
MUSCLE CELL DIFFERENTIATION |
24 |
237 |
3.005e-05 |
0.0006144 |
228 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
12 |
73 |
3.01e-05 |
0.0006144 |
229 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
11 |
62 |
3.081e-05 |
0.000626 |
230 |
REGULATION OF RESPONSE TO STRESS |
90 |
1468 |
3.102e-05 |
0.0006276 |
231 |
PATTERN SPECIFICATION PROCESS |
35 |
418 |
3.344e-05 |
0.0006737 |
232 |
BRANCH ELONGATION OF AN EPITHELIUM |
6 |
17 |
3.406e-05 |
0.0006831 |
233 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
38 |
472 |
3.697e-05 |
0.0007382 |
234 |
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
5 |
11 |
3.821e-05 |
0.0007597 |
235 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
61 |
898 |
3.841e-05 |
0.0007606 |
236 |
LIPID PHOSPHORYLATION |
14 |
99 |
3.882e-05 |
0.0007655 |
237 |
REGULATION OF CELLULAR COMPONENT SIZE |
30 |
337 |
3.925e-05 |
0.0007705 |
238 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
10 |
53 |
4.055e-05 |
0.0007928 |
239 |
EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS |
7 |
25 |
4.078e-05 |
0.000794 |
240 |
IMMUNE SYSTEM DEVELOPMENT |
44 |
582 |
4.221e-05 |
0.0008184 |
241 |
HEART MORPHOGENESIS |
22 |
212 |
4.396e-05 |
0.0008452 |
242 |
RESPIRATORY SYSTEM DEVELOPMENT |
21 |
197 |
4.39e-05 |
0.0008452 |
243 |
BRAIN MORPHOGENESIS |
8 |
34 |
4.553e-05 |
0.0008718 |
244 |
CELL DEATH |
66 |
1001 |
4.602e-05 |
0.0008775 |
245 |
VENTRICULAR SEPTUM DEVELOPMENT |
10 |
54 |
4.8e-05 |
0.0009117 |
246 |
APPENDAGE DEVELOPMENT |
19 |
169 |
4.848e-05 |
0.0009133 |
247 |
LIMB DEVELOPMENT |
19 |
169 |
4.848e-05 |
0.0009133 |
248 |
POSITIVE REGULATION OF ENDOCYTOSIS |
15 |
114 |
4.918e-05 |
0.0009227 |
249 |
POSITIVE REGULATION OF CELL ADHESION |
32 |
376 |
5.267e-05 |
0.0009843 |
250 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
42 |
552 |
5.432e-05 |
0.001011 |
251 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
11 |
66 |
5.63e-05 |
0.001044 |
252 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
10 |
55 |
5.659e-05 |
0.001045 |
253 |
NEGATIVE REGULATION OF LOCOMOTION |
25 |
263 |
5.925e-05 |
0.00109 |
254 |
LUNG MORPHOGENESIS |
9 |
45 |
6.08e-05 |
0.001114 |
255 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
17 |
144 |
6.466e-05 |
0.001175 |
256 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
17 |
144 |
6.466e-05 |
0.001175 |
257 |
RESPONSE TO NITROGEN COMPOUND |
58 |
859 |
7.032e-05 |
0.001268 |
258 |
HIPPO SIGNALING |
7 |
27 |
7.026e-05 |
0.001268 |
259 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
24 |
250 |
7.079e-05 |
0.001272 |
260 |
WOUND HEALING |
37 |
470 |
7.445e-05 |
0.001332 |
261 |
COGNITION |
24 |
251 |
7.538e-05 |
0.001344 |
262 |
REGULATION OF ORGANELLE ORGANIZATION |
74 |
1178 |
7.667e-05 |
0.001362 |
263 |
CELL PROLIFERATION |
48 |
672 |
7.861e-05 |
0.001391 |
264 |
STEM CELL DIFFERENTIATION |
20 |
190 |
7.899e-05 |
0.001392 |
265 |
CARDIAC VENTRICLE DEVELOPMENT |
14 |
106 |
8.344e-05 |
0.001465 |
266 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
98 |
1676 |
8.435e-05 |
0.001475 |
267 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
20 |
191 |
8.499e-05 |
0.001481 |
268 |
NEGATIVE REGULATION OF GLIOGENESIS |
8 |
37 |
8.706e-05 |
0.001512 |
269 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
16 |
134 |
9.18e-05 |
0.001582 |
270 |
MESENCHYMAL CELL DIFFERENTIATION |
16 |
134 |
9.18e-05 |
0.001582 |
271 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
6 |
20 |
9.623e-05 |
0.001652 |
272 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
27 |
304 |
9.778e-05 |
0.001673 |
273 |
CANONICAL WNT SIGNALING PATHWAY |
13 |
95 |
0.0001028 |
0.001751 |
274 |
POSITIVE REGULATION OF CELL DEATH |
44 |
605 |
0.0001034 |
0.001755 |
275 |
REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC |
7 |
29 |
0.0001152 |
0.001948 |
276 |
CELL CYCLE |
80 |
1316 |
0.0001158 |
0.001953 |
277 |
MULTICELLULAR ORGANISMAL SIGNALING |
15 |
123 |
0.0001186 |
0.001993 |
278 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
48 |
684 |
0.0001201 |
0.00201 |
279 |
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
12 |
84 |
0.0001238 |
0.002057 |
280 |
POSITIVE REGULATION OF OSSIFICATION |
12 |
84 |
0.0001238 |
0.002057 |
281 |
FORMATION OF PRIMARY GERM LAYER |
14 |
110 |
0.0001252 |
0.002072 |
282 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
8 |
39 |
0.0001293 |
0.002125 |
283 |
NEGATIVE CHEMOTAXIS |
8 |
39 |
0.0001293 |
0.002125 |
284 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
6 |
21 |
0.0001302 |
0.002133 |
285 |
GLAND DEVELOPMENT |
32 |
395 |
0.0001328 |
0.002169 |
286 |
REGULATION OF CELL ACTIVATION |
37 |
484 |
0.0001354 |
0.002202 |
287 |
PALLIUM DEVELOPMENT |
17 |
153 |
0.0001378 |
0.002233 |
288 |
PALATE DEVELOPMENT |
12 |
85 |
0.000139 |
0.002246 |
289 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
9 |
50 |
0.0001438 |
0.002299 |
290 |
RESPONSE TO ALCOHOL |
30 |
362 |
0.0001434 |
0.002299 |
291 |
RHO PROTEIN SIGNAL TRANSDUCTION |
9 |
50 |
0.0001438 |
0.002299 |
292 |
REGULATION OF ORGAN GROWTH |
11 |
73 |
0.0001447 |
0.002305 |
293 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
32 |
397 |
0.0001457 |
0.002314 |
294 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
17 |
154 |
0.0001492 |
0.002361 |
295 |
POSITIVE REGULATION OF DNA REPLICATION |
12 |
86 |
0.0001557 |
0.002457 |
296 |
GASTRULATION |
17 |
155 |
0.0001615 |
0.002538 |
297 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
9 |
51 |
0.0001684 |
0.002639 |
298 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
55 |
829 |
0.0001694 |
0.002645 |
299 |
POSITIVE REGULATION OF BINDING |
15 |
127 |
0.0001703 |
0.00265 |
300 |
REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
6 |
22 |
0.000173 |
0.002683 |
301 |
BONE DEVELOPMENT |
17 |
156 |
0.0001746 |
0.002699 |
302 |
POSITIVE REGULATION OF CELL CYCLE |
28 |
332 |
0.0001765 |
0.002719 |
303 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
43 |
602 |
0.0001833 |
0.002815 |
304 |
REGULATION OF PHOSPHATASE ACTIVITY |
15 |
128 |
0.0001859 |
0.002838 |
305 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
8 |
41 |
0.0001871 |
0.002838 |
306 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
21 |
218 |
0.0001872 |
0.002838 |
307 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
8 |
41 |
0.0001871 |
0.002838 |
308 |
ACTIVATION OF MAPKK ACTIVITY |
9 |
52 |
0.0001966 |
0.002969 |
309 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
84 |
1423 |
0.0002061 |
0.003103 |
310 |
EPITHELIAL CELL PROLIFERATION |
12 |
89 |
0.0002168 |
0.003254 |
311 |
PATTERNING OF BLOOD VESSELS |
7 |
32 |
0.0002237 |
0.003336 |
312 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
8 |
42 |
0.0002231 |
0.003336 |
313 |
GLIOGENESIS |
18 |
175 |
0.0002362 |
0.0035 |
314 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
18 |
175 |
0.0002362 |
0.0035 |
315 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
32 |
408 |
0.0002388 |
0.003528 |
316 |
NEGATIVE REGULATION OF BINDING |
15 |
131 |
0.0002405 |
0.003541 |
317 |
PEPTIDYL AMINO ACID MODIFICATION |
55 |
841 |
0.0002428 |
0.003553 |
318 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
14 |
117 |
0.0002422 |
0.003553 |
319 |
MAINTENANCE OF CELL NUMBER |
15 |
132 |
0.0002615 |
0.003814 |
320 |
REGULATION OF NEURON APOPTOTIC PROCESS |
19 |
192 |
0.0002644 |
0.003845 |
321 |
NEGATIVE REGULATION OF JNK CASCADE |
7 |
33 |
0.0002742 |
0.003962 |
322 |
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT |
7 |
33 |
0.0002742 |
0.003962 |
323 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
24 |
274 |
0.0002873 |
0.004138 |
324 |
NEGATIVE REGULATION OF PROTEIN BINDING |
11 |
79 |
0.0002957 |
0.004246 |
325 |
REGULATION OF B CELL PROLIFERATION |
9 |
55 |
0.0003052 |
0.004349 |
326 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
5 |
16 |
0.0003056 |
0.004349 |
327 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN |
5 |
16 |
0.0003056 |
0.004349 |
328 |
INTERACTION WITH HOST |
15 |
134 |
0.0003083 |
0.004373 |
329 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
10 |
67 |
0.0003115 |
0.004406 |
330 |
REGULATION OF WNT SIGNALING PATHWAY |
26 |
310 |
0.0003231 |
0.004542 |
331 |
EXOCYTOSIS |
26 |
310 |
0.0003231 |
0.004542 |
332 |
SKIN DEVELOPMENT |
20 |
211 |
0.0003264 |
0.004574 |
333 |
REGULATION OF DNA BINDING |
12 |
93 |
0.0003289 |
0.004595 |
334 |
RESPONSE TO FLUID SHEAR STRESS |
7 |
34 |
0.0003335 |
0.004646 |
335 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
9 |
56 |
0.000351 |
0.00486 |
336 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
9 |
56 |
0.000351 |
0.00486 |
337 |
CHEMICAL HOMEOSTASIS |
56 |
874 |
0.0003556 |
0.00491 |
338 |
REGULATION OF BLOOD CIRCULATION |
25 |
295 |
0.0003577 |
0.004924 |
339 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
19 |
197 |
0.0003665 |
0.005018 |
340 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
17 |
166 |
0.0003667 |
0.005018 |
341 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
20 |
213 |
0.0003691 |
0.005037 |
342 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
6 |
25 |
0.0003706 |
0.005042 |
343 |
EMBRYONIC ORGAN MORPHOGENESIS |
24 |
279 |
0.0003746 |
0.005082 |
344 |
ACTIVATION OF MAPK ACTIVITY |
15 |
137 |
0.0003919 |
0.005301 |
345 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
16 |
152 |
0.0003973 |
0.005358 |
346 |
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
9 |
57 |
0.0004022 |
0.005409 |
347 |
REGULATION OF RECEPTOR BINDING |
5 |
17 |
0.0004188 |
0.005567 |
348 |
REGULATION OF ENERGY HOMEOSTASIS |
5 |
17 |
0.0004188 |
0.005567 |
349 |
REGULATION OF SISTER CHROMATID COHESION |
5 |
17 |
0.0004188 |
0.005567 |
350 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
5 |
17 |
0.0004188 |
0.005567 |
351 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
16 |
153 |
0.0004276 |
0.005668 |
352 |
CARDIOCYTE DIFFERENTIATION |
12 |
96 |
0.0004422 |
0.005845 |
353 |
NEURAL PRECURSOR CELL PROLIFERATION |
10 |
70 |
0.0004474 |
0.005898 |
354 |
PROTEIN UBIQUITINATION |
43 |
629 |
0.0004637 |
0.006095 |
355 |
NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION |
6 |
26 |
0.0004656 |
0.006102 |
356 |
RESPONSE TO INORGANIC SUBSTANCE |
35 |
479 |
0.0004716 |
0.006146 |
357 |
SKELETAL SYSTEM MORPHOGENESIS |
19 |
201 |
0.0004713 |
0.006146 |
358 |
KIDNEY EPITHELIUM DEVELOPMENT |
14 |
125 |
0.000481 |
0.006236 |
359 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
40 |
573 |
0.0004811 |
0.006236 |
360 |
CORTICAL CYTOSKELETON ORGANIZATION |
7 |
36 |
0.0004827 |
0.006239 |
361 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
13 |
111 |
0.0004925 |
0.006347 |
362 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
11 |
84 |
0.0005072 |
0.006502 |
363 |
TISSUE MIGRATION |
11 |
84 |
0.0005072 |
0.006502 |
364 |
NEGATIVE REGULATION OF NEURON DEATH |
17 |
171 |
0.0005177 |
0.006618 |
365 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
16 |
156 |
0.0005307 |
0.006729 |
366 |
REGULATION OF NEURON DEATH |
22 |
252 |
0.0005291 |
0.006729 |
367 |
PROTEIN LOCALIZATION TO NUCLEUS |
16 |
156 |
0.0005307 |
0.006729 |
368 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
5 |
18 |
0.0005608 |
0.006991 |
369 |
CARDIAC SEPTUM DEVELOPMENT |
11 |
85 |
0.0005619 |
0.006991 |
370 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
5 |
18 |
0.0005608 |
0.006991 |
371 |
NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS |
5 |
18 |
0.0005608 |
0.006991 |
372 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
20 |
220 |
0.0005595 |
0.006991 |
373 |
REGULATION OF CELL SIZE |
17 |
172 |
0.0005536 |
0.006991 |
374 |
POST ANAL TAIL MORPHOGENESIS |
5 |
18 |
0.0005608 |
0.006991 |
375 |
VESICLE MEDIATED TRANSPORT |
73 |
1239 |
0.0005711 |
0.007086 |
376 |
POSITIVE REGULATION OF B CELL PROLIFERATION |
7 |
37 |
0.000575 |
0.007116 |
377 |
REGULATION OF HEART CONTRACTION |
20 |
221 |
0.0005927 |
0.007312 |
378 |
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY |
9 |
60 |
0.000594 |
0.007312 |
379 |
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
55 |
873 |
0.0005991 |
0.007355 |
380 |
REGULATION OF ERK1 AND ERK2 CASCADE |
21 |
238 |
0.0006106 |
0.00744 |
381 |
POSITIVE REGULATION OF GROWTH |
21 |
238 |
0.0006106 |
0.00744 |
382 |
REGULATION OF DEPHOSPHORYLATION |
16 |
158 |
0.0006108 |
0.00744 |
383 |
SECRETION BY CELL |
35 |
486 |
0.0006126 |
0.007442 |
384 |
SENSORY ORGAN MORPHOGENESIS |
21 |
239 |
0.0006449 |
0.007814 |
385 |
CARDIAC CHAMBER DEVELOPMENT |
15 |
144 |
0.0006659 |
0.007964 |
386 |
MEMBRANE DEPOLARIZATION |
9 |
61 |
0.0006725 |
0.007964 |
387 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
8 |
49 |
0.000666 |
0.007964 |
388 |
REGULATION OF MEMBRANE POTENTIAL |
27 |
343 |
0.0006727 |
0.007964 |
389 |
RESPONSE TO EXTERNAL STIMULUS |
100 |
1821 |
0.0006727 |
0.007964 |
390 |
TUBE FORMATION |
14 |
129 |
0.0006616 |
0.007964 |
391 |
NUCLEAR IMPORT |
14 |
129 |
0.0006616 |
0.007964 |
392 |
PROSTATE GLAND GROWTH |
4 |
11 |
0.0006693 |
0.007964 |
393 |
NEGATIVE REGULATION OF CELL ADHESION |
20 |
223 |
0.0006642 |
0.007964 |
394 |
CELLULAR RESPONSE TO ACID CHEMICAL |
17 |
175 |
0.0006745 |
0.007965 |
395 |
COLLAGEN FIBRIL ORGANIZATION |
7 |
38 |
0.0006808 |
0.00802 |
396 |
CELLULAR RESPONSE TO PEPTIDE |
23 |
274 |
0.0006902 |
0.00811 |
397 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
10 |
74 |
0.000702 |
0.008196 |
398 |
GASTRULATION WITH MOUTH FORMING SECOND |
6 |
28 |
0.0007116 |
0.008196 |
399 |
POSITIVE REGULATION OF TELOMERASE ACTIVITY |
6 |
28 |
0.0007116 |
0.008196 |
400 |
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT |
6 |
28 |
0.0007116 |
0.008196 |
401 |
REGULATION OF EXTENT OF CELL GROWTH |
12 |
101 |
0.0007037 |
0.008196 |
402 |
T CELL MEDIATED IMMUNITY |
6 |
28 |
0.0007116 |
0.008196 |
403 |
REGULATION OF SPROUTING ANGIOGENESIS |
6 |
28 |
0.0007116 |
0.008196 |
404 |
REGULATED EXOCYTOSIS |
20 |
224 |
0.0007026 |
0.008196 |
405 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
5 |
19 |
0.0007362 |
0.008459 |
406 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
9 |
62 |
0.0007593 |
0.008698 |
407 |
REGULATION OF PEPTIDE SECRETION |
19 |
209 |
0.0007608 |
0.008698 |
408 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
8 |
50 |
0.0007655 |
0.00873 |
409 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
18 |
193 |
0.0007696 |
0.008756 |
410 |
REGIONALIZATION |
25 |
311 |
0.0007763 |
0.008811 |
411 |
SENSORY PERCEPTION OF PAIN |
10 |
75 |
0.0007815 |
0.008848 |
412 |
MUSCLE ORGAN DEVELOPMENT |
23 |
277 |
0.0008009 |
0.009045 |
413 |
LIPID MODIFICATION |
19 |
210 |
0.000806 |
0.00908 |
414 |
REGULATION OF RECEPTOR ACTIVITY |
13 |
117 |
0.0008155 |
0.009166 |
415 |
CONNECTIVE TISSUE DEVELOPMENT |
18 |
194 |
0.0008175 |
0.009166 |
416 |
POSITIVE REGULATION OF CELL DIVISION |
14 |
132 |
0.0008321 |
0.009307 |
417 |
CIRCULATORY SYSTEM PROCESS |
28 |
366 |
0.0008402 |
0.009353 |
418 |
REGULATION OF CIRCADIAN RHYTHM |
12 |
103 |
0.0008395 |
0.009353 |
419 |
REGULATION OF MUSCLE ADAPTATION |
9 |
63 |
0.0008549 |
0.009494 |
420 |
EPIDERMIS MORPHOGENESIS |
6 |
29 |
0.0008672 |
0.009569 |
421 |
STEM CELL DIVISION |
6 |
29 |
0.0008672 |
0.009569 |
422 |
EAR DEVELOPMENT |
18 |
195 |
0.0008679 |
0.009569 |
423 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
8 |
51 |
0.0008766 |
0.009643 |
424 |
REGULATION OF ION TRANSPORT |
40 |
592 |
0.0009032 |
0.009912 |